期刊文献+

VAMP加逆转剂治疗难治性急性淋巴细胞白血病的体内、外研究 被引量:1

The Study of VAMP Combined with Multidrug Resistance Modulators to Treat Refractory ALL in Vitro and in Vivo
下载PDF
导出
摘要 目的 :观察VAMP方案加维拉帕米或环孢菌素A逆转治疗难治性ALL的疗效。方法 :选择原发和继发耐药的ALL患者 13例 ,采用VAMP方案加维拉帕米或环孢菌素A逆转体内、外研究。结果 :13例ALL中 7例达CR ,3例达PR ,3例无效。体外VAMP方案加VRP或CSA可有效逆转耐药。结论 :采用VAMP方案加维拉帕米或环孢菌素A逆转治疗难治性ALL ,可取得较好的疗效 ,为争取移植治疗创造了条件。 objective:To investigate th effect of combined with verapamil or cyclosporin A to treat refractory ALL.Methods:13patients with primary or acquired drug-resistance ALL were studied by treating with VAMPcombined with verapamil or cyclosporin A in vitro and in vivo.Results:7 of 13 patients were CR,3 PR and 3 no effect.The regimen of VAMP combined with VRP or CsA can reverse drug-resistance in vitro .Conclusion:The good curative effect could be obtained by VAMP regimen combined with VRP or CsA to treat refractory ALL,and could establish condition for transplantation.
出处 《实用临床医学(江西)》 CAS 2004年第1期16-18,共3页 Practical Clinical Medicine
基金 江西省卫生厅资助课题
关键词 急性淋巴细胞白血病 化学治疗 耐药 维拉帕米 环孢菌素A 逆转 leukemia chemotharapy resistance verapamil cyclosporrime A reversal
  • 相关文献

参考文献2

二级参考文献13

  • 1Pieters By R,Loonen A. H,Huismans D. R,et al. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with inproved culture conditions[J]. Blood, 1990, 76(11) :2327-2336.
  • 2Hwang W-S,Chan L-M, Huang SH,et al. Prediction of chwmotherapy response in human lwukemia using in vitro chemosensitivity test[J]. Leukes, 1993,17: 685 - 688.
  • 3Preisler HD,Raza A. Larson R,et al. Some reasons for the lack of progres in the treatment if acute myelogenous leukemiaLa reviow of three consecutive trials of the treatment of poor prognosis patients[J], Leuk Res, 1991,15: 773- 780.
  • 4Preisler HD,Raza A. Cell cycle studies in acute myelogens leukemia, Leukemia[J], 1992,6: 751 - 753.
  • 5Weisenthal LM,Lippmam ME.Clonogenic and nonclonogenic in vitro chemosensitivity assays. Cancer Treatment Reports . 1985
  • 6Mosmann T.Rapid colorimetric assay for cellular growth and survival:application to proliferation and cytotoxicity assays. Journal of Immunological Methods . 1983
  • 7Carmichael J,DeGraff G,Gazdar AF,et al.Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Research . 1987
  • 8Alley MC,Scudiero DA,Monks A,et al.Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Research . 1988
  • 9Hwang W-S,Chen L-M,Huang S-H,et al.Prediction of chemotherapy response in human leukemia using in vitro chemosensitivity test. Leukemia Research . 1993
  • 10Preisler HD,Raza A,Larson R,et al.Some reasons for the lack of progress in the treatment of acute myelogenous leukemia: a reviow of three consecutive trials of the treatment of poor prognosis patients. Leukemia Research . 1991

共引文献16

同被引文献6

  • 1孟海涛,林修基,林茂芳.CsA逆转急性白血病细胞多药耐药的药物敏感性实验观察[J].中华血液学杂志,1996,17(6):319-320. 被引量:6
  • 2邓家栋.邓家栋血液病学[M].上海:上海科学技术出版社,2001:991.
  • 3SAUVAGE V,AUBERT D,BONHOMME A,et al.P-glycoprotein Inhibitors Modulate Accumulation and Efflux of Xenobiotics in Extra and Intracellular Toxoplasma Gondii[J].Molecular and Biochemical Parasitology,2004,134(1):89-95.
  • 4DAENEN S,HOLT B van der,VERHOEF GEG,et al.Addition of Cyclosporin A to the Combination of Mitoxantrone and Etoposide to Overcome Resistance to Chemotherapy in Refractory or Relapsing Acute Myeloid Leukaemia:A Randomised Phase II Trial from HOVON,the Dutch-Belgian Haemato-Oncology Working Group(HOVON) and Swiss Group for Clinical Cancer Research (SAKK) Trial[J].Leuk Res,2004,28(10):1 057-1 067.
  • 5SCHULDES H,DOLDERER J H,ZIMMER G,et al.Reversal of Multidrug Resistance and Increase in Plasma Membrane Fluidity in CHO Cells with R-verapamil and Bile Salts[J].Eur J Cancer,2001,37(5):660-667.
  • 6肖青,胡妮妮,黄宗干.VAMP方案治疗难治性急性淋巴细胞白血病近期疗效观察[J].重庆医学,2001,30(6):549-549. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部